Table 6.
Characteristics of primary pancreatic invasive ductal adenocarcinoma.
| Variables | n = 16 |
|---|---|
| Diagnostic accuracy of EUS-TA, % | 87.5 (14/16) |
| Tumor location, n (%) | |
| Pancreatic head | 8 (50) |
| Pancreatic body or tail | 8 (50) |
| Resectable, n (%) | 16 (100) |
| Treatment, n (%) | |
| Surgery | 12 (75) |
| Neoadjuvant chemotherapy | 11 (91.7) |
| Upfront surgery | 1 (8.3) |
| Radiation | 2 (12.5) |
| Follow-up (nontolerance for surgery) | 2 (12.5) |
| Surgical method, n (%) | |
| Pancreatoduodenectomy | 5 (41.7) |
| Distal pancreatectomy | 7 (58.3) |
| Final pathological staging after surgery, n (%) | |
| 0 | 2 (16.7) |
| IA | 6 (50) |
| IB | 4 (33.3) |
| Median follow-up period (range), d | 799 (386–1764) |
EUS-TA: EUS tissue acquisition.